Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

JOHNS HOPKINS UNIVERSITY

🇳🇦Namibia

Country: 🇳🇦Namibia

Ownership: -

Established: 1876-01-01

Employees: 19.4K

Market Cap: -

Website: https://www.jhu.edu/

Clinical Trials

ETV Versus Shunt Surgery in Normal Pressure Hydrocephalus

Terminated

Conditions: Hydrocephalus

Interventions: Procedure: Ventriculoperitoneal Shunt Placement
Procedure: Endoscopic Third Ventriculostomy(ETV)

First Posted Date: 2009-07-24

Last Posted Date: 2012-10-03

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 13

Registration Number: NCT00946127

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

Relapse Prevention With Varenicline

Phase 4

Completed

Conditions: Substance-Related Disorders
Recurrence
Smoking Cessation

Interventions: Drug: Placebo
Drug: Varenicline

First Posted Date: 2009-07-23

Last Posted Date: 2017-08-03

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 104

Registration Number: NCT00944554

Locations: 🇺🇸
Behavioral Pharmacology Research Unit, Baltimore, Maryland, United States

Sildenafil for Treatment of Priapism in Men With Sickle Cell Anemia

Phase 2

Completed

Conditions: Sickle Cell Disease
Priapism

Interventions: Other: placebo
Drug: sildenafil

First Posted Date: 2009-07-17

Last Posted Date: 2017-04-13

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 13

Registration Number: NCT00940901

Locations: 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States

High Dose Cyclophosphamide Followed by Glatiramer Acetate in the Treatment of Relapsing Remitting Multiple Sclerosis

Phase 2

Withdrawn

Conditions: Relapsing Remitting Multiple Sclerosis

Interventions: Drug: Cyclophosphamide/Glatiramer acetate

First Posted Date: 2009-07-15

Last Posted Date: 2018-09-26

Lead Sponsor: Johns Hopkins University

Registration Number: NCT00939549

Locations: 🇺🇸
Johns Hopkins Hospital Multiple Sclerosis Center, Baltimore, Maryland, United States

SAR 1118 in Human Subjects Undergoing Pars Plana Vitrectomy

Phase 1

Terminated

Conditions: Diabetic Macular Edema (DME)
Pars Plana Vitrectomy

Interventions: Drug: SAR 1118 0.1%
Drug: SAR 1118 1.0%
Drug: SAR 1118 5.0%

First Posted Date: 2009-07-10

Last Posted Date: 2017-05-10

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 30

Registration Number: NCT00936520

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

Acupressure and Acupuncture as an Intervention With Children With Autism II

Not Applicable

Completed

Conditions: Autism Spectrum Disorder

Interventions: Device: Acupressure and Acupuncture

First Posted Date: 2009-07-09

Last Posted Date: 2017-04-18

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 10

Registration Number: NCT00935701

Locations: 🇺🇸
Kennedy Krieger Institute, Baltimore, Maryland, United States

Combined Non-invasive Coronary Angiography and Myocardial Perfusion Imaging Using 320 Detector Computed Tomography

Phase 3

Completed

Conditions: Coronary Artery Disease
Vascular Diseases
Arterial Occlusive Diseases
Coronary Disease
Heart Diseases
Myocardial Ischemia
Arteriosclerosis
Ischemia

Interventions: Procedure: 320 Volume Detector Computed Tomography

First Posted Date: 2009-07-08

Last Posted Date: 2018-09-05

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 444

Registration Number: NCT00934037

Locations: 🇺🇸
Johns Hopkins School of Medicine, Baltimore, Maryland, United States
🇺🇸
National Heart Lung and Blood Institute (NHLBI), Bethesda, Maryland, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

and more 13 locations

Culturally Sensitive Behavioral Interventions to Enhance Living Kidney Donation / Living Kidney Transplantation

Not Applicable

Completed

Conditions: Chronic Kidney Disease

Interventions: Behavioral: TALK Standard
Behavioral: Usual Care
Behavioral: TALK PLUS

First Posted Date: 2009-07-03

Last Posted Date: 2017-12-11

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 145

Registration Number: NCT00932334

Evaluating the Effects of a Diet and Exercise Program in People With Type 2 Diabetes or Prediabetes: (The SHAPE3 Study)

Phase 4

Completed

Conditions: Overweight
Obesity
Type 2 Diabetes
Prediabetes

Interventions: Behavioral: Weight loss diet
Behavioral: Weight loss diet plus exercise

First Posted Date: 2009-06-25

Last Posted Date: 2013-04-04

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 77

Registration Number: NCT00928005

Locations: 🇺🇸
Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States

PRIDE: Preventing Respiratory Illnesses During Childhood Study

Not Applicable

Completed

Conditions: Tobacco Smoke Pollution

Interventions: Behavioral: Educational Program for ETS Reduction
Behavioral: Motivational Interviewing Intervention for ETS Reduction

First Posted Date: 2009-06-24

Last Posted Date: 2017-08-24

Lead Sponsor: Johns Hopkins University

Target Recruit Count: 350

Registration Number: NCT00927264

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy